<?xml version="1.0" encoding="ISO-8859-1"?>
<BiblioData DataBase="ESPACENET" Version="221" Datum="2012-07-14">
<SubDatabase>
espacenet
</SubDatabase>
<Title>
FLUORESCENT SEMICONDUCTOR MICROPARTICLE, METHOD FOR PRODUCTION OF THE MICROPARTICLE, FLUORESCENT LABELING AGENT FOR BIOLOGICAL SUBSTANCE USING THE MICROPARTICLE, AND BIOIMAGING METHOD USING THE MICROPARTICLE
</Title>
<PublicationNumber>
EP2063268A1
</PublicationNumber>
<Inventor>
<Name>
TSUKADA KAZUYA [JP]
</Name>
<Name>
GOAN KAZUYOSHI [JP]
</Name>
<Name>
FURUSAWA NAOKO [JP]
</Name>
<Name>
TSUKADA, KAZUYA
</Name>
<Name>
GOAN, KAZUYOSHI
</Name>
<Name>
FURUSAWA, NAOKO
</Name>
</Inventor>
<Applicant>
<Name>
KONICA MINOLTA MED &amp; GRAPHIC [JP]
</Name>
<Name>
KONICA MINOLTA MEDICAL &amp; GRAPHIC, INC
</Name>
</Applicant>
<RequestedPatent>
EP2063268
</RequestedPatent>
<ApplicationElem>
<Number>
EP20070792855
</Number>
</ApplicationElem>
<ApplicationDate>
2007-08-22
</ApplicationDate>
<PriorityElem>
<PriorityNumber>
WO2007JP66257
</PriorityNumber>
<PriorityDate>
2007-08-22
</PriorityDate>
<PriorityNumber>
JP20060250714
</PriorityNumber>
<PriorityDate>
2006-09-15
</PriorityDate>
</PriorityElem>
<IPC>
<Class>
C12Q1/02
</Class>
<Class>
G01N21/64
</Class>
<Class>
G01N21/78
</Class>
<Class>
G01N33/533
</Class>
<Class>
G01N33/543
</Class>
<Class>
G01N33/553
</Class>
</IPC>
<NCL>
<Class>
B82Y15/00
</Class>
<Class>
G01N21/64S
</Class>
<Class>
G01N33/533
</Class>
<Class>
G01N33/543D6
</Class>
<Class>
G01N33/58J
</Class>
</NCL>
<Abstract>
Disclosed is a fluorescent semiconductor particle having a core/shell structure composed of a core particle as a semiconductor particle, and a shell layer by which the core particle is covered, wherein the core particle has a different chemical composition from that of the shell layer;  the core particle has an average particle diameter of 1 - 15 nm and a specific gravity of 1.0 - 3.0;  and the fluorescent semiconductor particle having the core/shell structure has a specific gravity of 0.8 - 3.2
</Abstract>
<Claims>
<P>
1. A fluorescent semiconductor particle having a core/shell structure composed of a core particle as a semiconductor particle, and a shell layer by which the core particle is covered,
</P>
<P>
wherein the core particle has a different chemical composition from that of the shell layer; the core particle has an average particle diameter of 1 - 15 nm and a specific gravity of 1.0 - 3.0; and the fluorescent semiconductor particle having the core/shell structure has a specific gravity of 0.8 - 3.2.
</P>
<P>
2. The fluorescent semiconductor particle of Claim 1,
</P>
<P>
wherein the specific gravity of the shell layer is adjusted by a volume ratio of the core particle to the shell layer, in such a manner that the fluorescent semiconductor particle having the core/shell structure has a specific gravity of 0.8 - 3.2.
</P>
<P>
3. The fluorescent semiconductor particle of Claim 1 or 2,
</P>
<P>
wherein the core particle has an average particle diameter of 1 - 10 nm, and the fluorescent semiconductor particle having the core/shell structure has an average particle diameter of 3 - 15 nm.
</P>
<P>
4. The fluorescent semiconductor particle of any one of Claims 1 - 3,
</P>
<P>
wherein the core particle has an average particle diameter of 1 - 5 nm, and the fluorescent semiconductor particle having the core/shell structure has an average particle diameter of 3 - 10 nm.
</P>
<P>
5. A method of manufacturing the fluorescent semiconductor particle of any one of Claims 1 - 4, comprising the step of:
</P>
<P>
forming the core particle or the shell layer via a liquid phase process.
</P>
<P>
6. A biosubstance fluorescent labeling agent comprising a surface modification compound comprising a functional group bonded to a biosubstance on a surface of the fluorescent semiconductor particle of any one of Claims 1 - 4 and a functional group bonded to the surface of the fluorescent semiconductor particle.
</P>
<P>
7. The biosubstance fluorescent labeling agent of Claim 6, having an average particle diameter of 1 - 20 nm.
</P>
<P>
8. The biosubstance fluorescent labeling agent of Claim 6 or 7, having an average particle diameter of 1 - 10 nm.
</P>
<P>
9. A bioimaging method comprising the step of:
</P>
<P>
conducting fluorescent dynamic imaging employing the biosubstance fluorescent labeling agent of any one of Claims 6 - 8.
</P>
</Claims>
<Also_published_as>
EP2063268A4;US2009280520A1;WO2008032535A1
</Also_published_as>
</BiblioData>
